Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126197221 | 12619722 | 1 | I | 20160721 | 20160803 | 20160803 | EXP | GB-VALIDUS PHARMACEUTICALS LLC-GB-2016VAL002365 | VALIDUS | 0.00 | F | Y | 0.00000 | 20160803 | PH | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126197221 | 12619722 | 1 | PS | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 80 MG, TWICE A DAY | Y | UNKNOWN | 16273 | 80 | MG | TABLET | |||||
| 126197221 | 12619722 | 2 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 75 MG, DAILY | Y | UNKNOWN | 0 | 75 | MG | MODIFIED-RELEASE TABLET | |||||
| 126197221 | 12619722 | 3 | SS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | 37.5 MG, UNK | Y | 0 | 37.5 | MG | MODIFIED-RELEASE TABLET | ||||||
| 126197221 | 12619722 | 4 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | UNK | Y | UNKNOWN | 0 | ||||||||
| 126197221 | 12619722 | 5 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 126197221 | 12619722 | 6 | C | CHLORHEXIDINE GLUCONATE. | CHLORHEXIDINE GLUCONATE | 1 | UNK | U | 0 | ||||||||||
| 126197221 | 12619722 | 7 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | UNK | U | 0 | ||||||||||
| 126197221 | 12619722 | 8 | C | DIPROBASE /01132701/ | 2 | UNK | U | 0 | |||||||||||
| 126197221 | 12619722 | 9 | C | NYSTATIN. | NYSTATIN | 1 | UNK | U | 0 | ||||||||||
| 126197221 | 12619722 | 10 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | UNK | U | 0 | ||||||||||
| 126197221 | 12619722 | 11 | C | PARACETAMOL | ACETAMINOPHEN | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126197221 | 12619722 | 1 | Product used for unknown indication |
| 126197221 | 12619722 | 2 | Product used for unknown indication |
| 126197221 | 12619722 | 4 | Product used for unknown indication |
| 126197221 | 12619722 | 5 | Product used for unknown indication |
| 126197221 | 12619722 | 6 | Product used for unknown indication |
| 126197221 | 12619722 | 7 | Product used for unknown indication |
| 126197221 | 12619722 | 8 | Product used for unknown indication |
| 126197221 | 12619722 | 9 | Product used for unknown indication |
| 126197221 | 12619722 | 10 | Product used for unknown indication |
| 126197221 | 12619722 | 11 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126197221 | 12619722 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126197221 | 12619722 | Acute kidney injury | |
| 126197221 | 12619722 | Chest pain | |
| 126197221 | 12619722 | Diarrhoea | |
| 126197221 | 12619722 | Dyspnoea | |
| 126197221 | 12619722 | Loss of consciousness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |